Friedhoff A J, Miller J C
Schizophr Bull. 1980;6(2):314-9. doi: 10.1093/schbul/6.2.314.
The level of platelet monoamine oxidase (MAO) has been found to be abnormally low in certain types of schizophrenia and in a number of other pathological conditions. It has been suggested that MAO in platelets may be a genetic marker for a subgroup of patients with schizophrenia; however, we have demonstrated that several nongenetic factors influence platelet MAO activity by affecting the platelet rather than the MAO enzyme protein. We have observed platelet MAO activities to be heterogeneously distributed in a given subject's platelet population, heavy platelet fractions having significantly higher specific activity than light platelet fractions. We have also found platelet MAO activity to be significantly correlated with mean platelet volume, platelet protein densities, and protein content per platelet. These changes, which might be induced by drugs and stress, could modify production, mobilization, and clearance of platelets and, hence, influence apparent MAO activity.
血小板单胺氧化酶(MAO)水平在某些类型的精神分裂症及许多其他病理状况下被发现异常低下。有人提出血小板中的MAO可能是精神分裂症患者亚组的一个遗传标志物;然而,我们已经证明,一些非遗传因素通过影响血小板而非MAO酶蛋白来影响血小板MAO活性。我们观察到在给定个体的血小板群体中,血小板MAO活性呈异质性分布,重血小板组分的比活性显著高于轻血小板组分。我们还发现血小板MAO活性与平均血小板体积、血小板蛋白密度及每个血小板的蛋白含量显著相关。这些可能由药物和应激诱导的变化,会改变血小板的生成、动员及清除,从而影响表观MAO活性。